Exicure, Inc. Common Stock

XCURNASDAQ • USD
1.07 USD
↘ 0.01 (0.65%)🟢PRE MARKET (AS OF 04:07 AM EST)
🟢Market: OPEN

Exicure, Inc. Common Stock (XCUR) is currently trading at $1.07. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, XCUR trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.99
High?$1.07
Low?$0.99
Prev. Close?$1.08
Volume?191
Avg. Volume?82.7K
VWAP?$0.99
Rel. Volume?0.00x
Bid / Ask
Bid?$0.86 × 100
Ask?$1.25 × 100
Spread?$0.39
Midpoint?$1.06
Valuation & Ratios
Market Cap?7.1M
Shares Out?6.5M
Float?3.8M
Float %?57.4%
P/E Ratio?N/A
P/B Ratio?7.24
EPS?-$1.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Employees
8
Market Cap
7.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-05-09
Address
2430 N. HALSTED ST.
CHICAGO, IL 60614
Phone: 847-673-1707
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-25.62Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.39%Low
Short Interest?52.2K
Days to Cover?1.0
Free Float3.8M
Avg Daily Volume76.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.56Weak
Quick Ratio?0.56Weak
Cash Ratio?0.41Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
26
7.24FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-847.9%WEAK▾
ROA?
S&P
3
-72.7%WEAK▾
Cash Flow & Enterprise
FCF?$-7023000
Enterprise Value?$5.4M
Fundamentals ratios updated end of day